COVID-19 SARS-CoV-2 preprints from medRxiv and bioRxiv

31,026 Articles (22,627 medRxiv, 8,399 bioRxiv)

Most recent first Previous |  Page 462: Articles 4611-4620  | Next

CD4+ and CD8+ T cell and antibody correlates of protection against Delta vaccine breakthrough infection: A nested case-control study within the PITCH study
Neale, I., Ali, M., Kronsteiner, B., Longet, S., Abraham, P., Deeks, A. S., Brown, A., Moore, S. C., Stafford, L., Dobson, S. L., Plowright, M., Newman, T. A. H., Wu, M. Y., Crick COVID Immunity Pipeline, , Carr, E. J., Beale, R., Otter, A. D., Hopkins, S., Hall, V., Tomic, A., Payne, R. P., Barnes, E., Richter, A., Duncan, C. J. A., Turtle, L., de Silva, T. I., Carroll, M., Lambe, T., Klenerman, P., Dunachie, S., PITCH Consortium
10.1101/2023.02.16.23285748 — Posted: 2023-02-17
Lives and Livelihood, Not Quite a Trade-Off: A Cross-Country Analysis of the Short-Term Impact of COVID-19 Mortality on Real GDP
Suah, J. L.
10.1101/2023.02.13.23285835 — Posted: 2023-02-17
Vaccine waning and immune escape drive the second surge of Omicron spread in Hong Kong: A modeling study
ZOU, Y., Lo, W.-C., Ming, W.-k., Yuan, H.-Y.
10.1101/2023.02.14.23285831 — Posted: 2023-02-17
Evaluation of SARS-CoV-2 isolation in cell culture from nasal/nasopharyngeal swabs or saliva specimens of patients with COVID-19
Yazawa, S., Yamazaki, E., Saga, Y., Itamochi, M., Inasaki, N., Shimada, T., Oishi, K., Tani, H.
10.1101/2023.02.16.528881 — Posted: 2023-02-17
A burns and COVID-19 shared stress responding gene network deciphers CD1C-CD141- DCs as the key cellular components in septic prognosis
Liang, Q., Wang, L., Xu, J., Lin, A., Wu, Y., Tao, Q., Zhang, B., Min, H., Song, S., Gao, Q.
10.1101/2023.02.17.528914 — Posted: 2023-02-17
Effectiveness of SARS-CoV-2 Vaccines against Omicron Infection and Severe Events: A Systematic Review and Meta-Analysis of Test-Negative Design Studies
Song, S., Madewell, Z. J., Liu, M., Longini, I. M., Yang, Y.
10.1101/2023.02.16.23286041 — Posted: 2023-02-17
CHARACTERISTICS OF ACUTE PSYCHIATRIC DISORDERS IN PATIENTS WITH COVID-19 IN A THIRD-LEVEL HOSPITAL IN PERU
De la Cruz-Amador, M. E., Aguirre-Quispe, W., Apaza-Aceituno, E. G., Valdivia-Francia, M. F.
10.1101/2023.02.16.23286046 — Posted: 2023-02-17
Characteristics and outcomes of 7620 Multiple Sclerosis patients admitted with COVID-19 in the United States
Ramphul, K., Sombans, S., Verma, R., Lohana, P., Dhillon, B. K., Mejias, S. G., Sanikommu, S., Ramphul, Y., Pekyi-Boateng, P. K.
10.1101/2023.02.15.23285994 — Posted: 2023-02-16
Estimates of protection against SARS-CoV-2 infection and severe COVID-19 in Germany before the 2022/2023 winter season - the IMMUNEBRIDGE project
Lange, B., Jaeger, V. K., Harries, M., Ruecker, V., Streeck, H., Blaschke, S., Petersmann, A., Toepfner, N., Nauck, M., Hassenstein, M. J., Dreier, M., von Holt, I., Budde, A., Bartz, A., Ortmann, J., Kurosinski, M.-A., Berner, R., Borsche, M., Brandhorst, G., Brinkmann, M., Budde, K., Deckena, M., Engels, G., Fenzlaff, M., Haertel, C., Hovardovska, O., Katalinic, A., Kehl, K., Kohls, M., Krueger, S., Lieb, W., Meyer-Schlinkmann, K. M., Pischon, T., Rosenkranz, D., Ruebsamen, N., Rupp, J., Schaefer, C., Schattschneider, M., Schlegtendal, A., Schlinkert, S., Schmidbauer, L., Schulze-Wundling, K
10.1101/2023.02.16.23285816 — Posted: 2023-02-16
COVID-19 Vaccine Acceptance in Nigeria: A Rapid Systematic Review and Meta-Analysis
Nnaemeka, V. C., Okafor, N. A., Orababa, O. Q., Anikwe, R., Onwe, R. O., Uzochukwu, N. P., Tsiterimam, T. S., Nwokoye, N. N., Ike, A. C.
10.1101/2023.02.16.23286008 — Posted: 2023-02-16

RSS  Collection RSS | JSON

The feeds linked above output metadata for the 100 most recent papers in the collection.To access the metadata for the entire collection in JSON or XML, visit the collection API.

Subject Areas
* The Clinical Trials and Epidemiology subject categories are now closed to new submissions following the completion of bioRxiv's clinical research pilot project and launch of the dedicated health sciences server medRxiv (submit.medrxiv.org). New papers that report results of Clinical Trials must now be submitted to medRxiv. Most new Epidemiology papers also should be submitted to medRxiv, but if a paper contains no health-related information, authors may choose to submit it to another bioRxiv subject category (e.g., Genetics or Microbiology).